Research Solutions, Inc.: Form 10-Q for the period ended Dec 31, 2020
Filed with the SEC on Feb 11, 2021 and accepted by EDGAR at Feb 11, 2021, 21:00 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-10-01 to 2020-12-31 | $7.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2020-07-01 to 2020-12-31 | $15.2m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2020-10-01 to 2020-12-31 | $5.1m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2020-07-01 to 2020-12-31 | $10.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2020-10-01 to 2020-12-31 | $2.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2020-07-01 to 2020-12-31 | $4.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2020-10-01 to 2020-12-31 | $2.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2020-07-01 to 2020-12-31 | $5.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-10-01 to 2020-12-31 | −$261.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2020-07-01 to 2020-12-31 | −$244.1k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-10-01 to 2020-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2020-07-01 to 2020-12-31 | $2.5k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-10-01 to 2020-12-31 | −$260.6k | us-gaap:NetIncomeLoss |
| Net income | 6 months2020-07-01 to 2020-12-31 | −$246.0k | us-gaap:NetIncomeLoss |
| Operating cash flow | 6 months2020-07-01 to 2020-12-31 | $884.5k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2020-07-01 to 2020-12-31 | $6.1k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2020-07-01 to 2020-12-31 | $127.3k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2020-12-31 | $10.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $15.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $15.4m | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $10.2m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2020-12-31 | $5.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-21-020656. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.